Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026
Key claim: The Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 (HR7936) seeks to expand domestic bioindustrial capacity to strengthen supply chains and energy resiliency.
Abstract
(HR7936 · 119th Congress) Latest action (2026-03-16): Referred to the House Committee on Science, Space, and Technology.
Why this matters
Bioindustrial manufacturing is an emerging leverage point where trade, supply-chain, and energy policy converge — feedstock chemicals, precursors, and biomanufactured inputs currently rely heavily on foreign (often Chinese) supply. A congressional scale-up framework, even at referral stage, signals that biomanufacturing may join semiconductors and critical minerals as a designated strategic sector eligible for domestic-preference programs, with downstream effects on importer sourcing and consumer input costs.